Tuesday, August 20, 2019 9:40:09 PM
Only item I noted on this latest 10-Q was ARCI booked $200K in Inventory for "Raw Material - Chips". Would be interesting to understand which version of the Monarch Pierre purchased. There was a Sequans Press Release 2 months ago on a new updated Version of the Monarch he chose to use. So if he bought prior versions, he already is a Day Late and a Dollar Short. The 5G Deployments are already in Trial on IOT and Verizon is selling the Sequans IOT solution for about $7 and that includes the POLTE Code. I got hands on a few. But one thing that still doesn't work well for my main solution is Z-Axis Altitude for In Building Coverage and it still isnt ported to the 700Mhz Public Safety Bands and that is where I had a serious Use case for Geotraq all last year. The market moves fast... pierre also appears to be marketing an IOT Sensor Solution based on the Monarch. The Monach has very limited Analog and Digital capabilities that only operate at 1.8, 3.3 or 5Volts. This is very limiting and he will miss the boat on what is considered "Industry 4.0" as well as the huge market in basic Water, Gas, and Electrical Sensors for Home and Business. I have tracked 4 huge Asset Location Deals Sequans did this year and last. Sad to say but who is going to go to a Reseller for any kind of Volume when you as a Buyer would just cut a deal with the Key MFG as well as the Network Carriers to operate the Solution.
We now are almost at the end of August.
ARCI is still Booking this Geotraq Patent at Acquisition Cost vs Fair Market Value. No license fees nor any lawsuits to Patent Infringement either. 2G and 3G Frequenxies and Technology are now all End of Life in favor of 4G/LTE and 5G Non Standalone Radios. The carriers are going to redeploy those 2G and 3G Radio Spectrum into 5G.
Here is a sample of my numbers from latest filing:
Geotraq still has a relatively high Burn Rate. They are still averaging what appears to be about $100K per month. It went down this past quarter. I was expecting it to go up as that would be normal if Pierre is in final stages of an actual product hitting the market. Especially after thatassive layoff last year. He would have to be fully outsourcing this project and then to be successful, you would begin to shift to more Marketing and Sales Costs and that doesn't appear to be happening beyond doing a few trade shows and Stripper Girl doing a few more videos
ARCI crossed over in the Negative on Working Capital (-$3.198) Million. That should trigger a lot of Lending and Loan Covenants.
Adjusted Book Value also is Negative. (-$893,000)
ARCI began task in ng on more Short Term Debt ($698,000) as well as the Accounts.
Payable increased to ($3.777) Million which indicates they are paying their Bill's later than normal or they took on new obligations. The former normally is true in many cases.
One new Lawsuit was added that puts upwards of roughly $2 Million in Liability.
Recycling Revenue continues to decline. I wrote on this before. There are only so many old appliances to recycle. The Cost of Goods also rose and that concerns me because this means some underlying cost is eating them alive and will continue to do so.
Recent JAN News
- JanOne Regains Compliance with Nasdaq's Listing Requirements • PR Newswire (US) • 03/15/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:22:34 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/09/2024 05:36:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:07:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:28:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:33:09 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/22/2023 09:00:42 PM
- JanOne to Present at the Dawson James 8th Annual Investment Conference • PR Newswire (US) • 09/21/2023 03:30:00 PM
- Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference • GlobeNewswire Inc. • 09/21/2023 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 08:33:01 PM
- JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference • PR Newswire (US) • 08/31/2023 05:30:00 PM
- JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain • PR Newswire (US) • 08/29/2023 05:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2023 09:20:13 PM
- JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting • PR Newswire (US) • 08/25/2023 06:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 08/24/2023 08:30:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:33:11 PM
- JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules • PR Newswire (US) • 08/22/2023 09:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/22/2023 04:54:17 PM
- JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules • PR Newswire (US) • 08/18/2023 11:00:00 PM
- JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting • PR Newswire (US) • 08/18/2023 04:42:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/16/2023 07:55:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 08:39:17 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/07/2023 08:19:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2023 08:24:10 PM
- JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain • PR Newswire (US) • 06/28/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM